# Liver Immune Tolerance Marker Utilization Study

> **NCT02541916** · NA · COMPLETED · sponsor: **University of Toronto** · enrollment: 69 (actual)

## Conditions studied

- Immunosuppression
- Immune Tolerance

## Interventions

- **OTHER:** Controlled weaning of immunosuppression

## Key facts

- **NCT ID:** NCT02541916
- **Lead sponsor:** University of Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2021-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02541916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02541916, "Liver Immune Tolerance Marker Utilization Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02541916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*